MARKET

CLLS

CLLS

Cellectis
NASDAQ
4.840
+0.060
+1.26%
After Hours: 4.840 0 0.00% 16:04 12/31 EST
OPEN
4.730
PREV CLOSE
4.780
HIGH
4.880
LOW
4.620
VOLUME
73.57K
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.100
MARKET CAP
350.05M
P/E (TTM)
-27.6256
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLLS last week (1222-1226)?
Weekly Report · 12/29/2025 09:36
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 12/23/2025 14:47
Cellectis Initiated at Buy by Clear Street
Dow Jones · 12/23/2025 10:13
Cellectis Price Target Announced at $9.00/Share by Clear Street
Dow Jones · 12/23/2025 10:13
Clear Street Initiates Coverage On Cellectis with Buy Rating, Announces Price Target of $9
Benzinga · 12/23/2025 10:02
Cellectis initiated with a Buy at Clear Street
TipRanks · 12/22/2025 21:25
Weekly Report: what happened at CLLS last week (1215-1219)?
Weekly Report · 12/22/2025 09:35
Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This
Seeking Alpha · 12/18/2025 13:52
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.